2017
DOI: 10.1097/mol.0000000000000442
|View full text |Cite
|
Sign up to set email alerts
|

Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice

Abstract: Purpose of review Previous epidemiological studies and studies in experimental animals have provided strong evidence for the atheroprotective effect of HDL and its major apoprotein, apoA-I. Identification of genetic loci associating apoA-I/HDL with cardiovascular disease is needed to establish a causal relationship. Recent findings Pharmacological interventions to increase apoA-I or HDL cholesterol levels in humans are not associated with reduction in atherosclerosis. GWAS studies in humans and hybrid mouse … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…On the other hand, there is no reduction in hepatic APO A1 mRNA (Rudling et al, 2002), suggesting that the two genes may not be coordinately regulated. Plasma HDL cholesterol concentration is positively associated with the concentration of APO A1; thus, APO A1 gene expression may be an important determinant of HDL cholesterol levels (Getz and Reardon, 2017). In humans, SFA rises APO A1 protein and HDL cholesterol concentration, while PUFA decreased HDL cholesterol concentrations (Dorfman et al, 2005;Hatahet et al, 2003;Lichtenstein et al, 1999;Plump, 1994).…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, there is no reduction in hepatic APO A1 mRNA (Rudling et al, 2002), suggesting that the two genes may not be coordinately regulated. Plasma HDL cholesterol concentration is positively associated with the concentration of APO A1; thus, APO A1 gene expression may be an important determinant of HDL cholesterol levels (Getz and Reardon, 2017). In humans, SFA rises APO A1 protein and HDL cholesterol concentration, while PUFA decreased HDL cholesterol concentrations (Dorfman et al, 2005;Hatahet et al, 2003;Lichtenstein et al, 1999;Plump, 1994).…”
Section: Discussionmentioning
confidence: 99%
“…This study has a number of limitations. Even though ApoE knockout is the most frequent murine model used in the studies investigated here, the biology triggered by different genetic models of hyperlipidemia can be different (summarized in Getz et al 42 ). In our integrated object, the majority of data sets are from the ApoE knockout model, but Pan et al included the Ldr knockout model as well.…”
Section: Article Informationmentioning
confidence: 99%